HIV resistance testing is used to identify genetic changes in HIV that may affect how well certain HIV medicines work. The results can be difficult to interpret because they may list mutations using combinations of letters and numbers. A healthcare professional considers the complete report rather than focusing on one mutation in isolation.
Understanding What Your HIV Resistance Report Shows
A resistance report may describe mutations detected in the HIV genome and indicate medicines or drug classes that could be affected. The meaning of a particular mutation can depend on the overall mutation pattern and the person's treatment history.
When reviewing the report, your healthcare team may explain:
- Detected mutations: These are genetic changes identified in the HIV sample tested.
- Drug susceptibility: The report may indicate whether particular medicines are expected to remain active or may have reduced activity.
- Drug classes: Results can involve classes such as nucleoside reverse transcriptase inhibitors, non nucleoside reverse transcriptase inhibitors, protease inhibitors, or integrase inhibitors.
- Treatment history: Previous HIV medicines and treatment interruptions can provide important context for interpreting resistance findings.
- Viral load: The amount of HIV in the blood can influence which testing methods are practical and how results are considered.
- Previous resistance results: Earlier tests may provide useful information because resistance patterns can change over time.
It is important not to interpret a single mutation as automatically meaning that a particular medicine will not work. Resistance is often evaluated by considering combinations of mutations and the person's complete clinical history.
Discussing Results and Treatment Decisions With Your Team
A resistance report is only one part of HIV care. Your healthcare team may combine the findings with current viral load results, medication history, adherence information, possible drug interactions, other medicines, and individual health considerations when discussing treatment options.
Useful questions to ask during an appointment include:
- What are the main mutations shown on my report?
- Which HIV medicines or drug classes may be affected?
- Does this result change my current treatment plan?
- How does my previous treatment history affect interpretation?
- Should another resistance test be considered?
- How will my viral load be monitored after a treatment change?
- Are there medication interactions I should know about?
- What should I do if I have difficulty taking my medicines consistently?
People should avoid stopping or changing HIV medicines based solely on a resistance report unless instructed by their healthcare professional. Taking HIV treatment as prescribed and attending recommended monitoring appointments can help the healthcare team evaluate whether treatment is working effectively.
Understanding resistance results can make medical appointments more productive. Asking the healthcare team to explain unfamiliar terms, drug classes, or mutation codes in plain language can help people participate more confidently in decisions about their HIV care.